Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
H.C. Wainwright Sticks to Their Buy Rating for Clovis Oncology (CLVS)
11:10am, Wednesday, 15'th Apr 2020
In a report released today,
Edward White
from H.C. Wainwright maintained a
Buy
rating on Clovis Oncology (
CLVS
–
Research Report
), with a price target of
$27.00
. The company’s shares closed las
BRIEF-Clovis Oncology Announces Debt Exchange Transaction
09:11pm, Tuesday, 14'th Apr 2020
Clovis Oncology Inc:
Clovis Oncology Announces Debt Exchange Transaction
09:08pm, Tuesday, 14'th Apr 2020
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that on April 14, 2020 it entered into a privately negotiated exchange agreement with a holder of its 2.50% Convertible Senior Notes due 2021 (the
Clovis Oncology (NASDAQ:CLVS) Cut to Underperform at Bank of America
11:26am, Sunday, 12'th Apr 2020
Bank of America lowered shares of Clovis Oncology (NASDAQ:CLVS) from a neutral rating to an underperform rating in a report issued on Thursday, Briefing.com Automated Import reports. The brokerage cur
Clovis Oncology (NASDAQ:CLVS) Downgraded by Zacks Investment Research
10:18am, Sunday, 12'th Apr 2020
Zacks Investment Research lowered shares of Clovis Oncology (NASDAQ:CLVS) from a buy rating to a hold rating in a report issued on Wednesday morning, Zacks.com reports. Zacks Investment Research curre
Clovis Oncology Analyst Turns Bearish Ahead Of PDUFA Date For Rubraca
02:04pm, Thursday, 09'th Apr 2020
Despite optimistic expectations concerning label expansion for Clovis Oncology Inc's (NASDAQ: CLVS) Rubraca to include prostate cancer, an analyst at BofA Securities is turning bearish on the stock. T
's Top Upgrades, Downgrades For April 9, 2020
02:02pm, Thursday, 09'th Apr 2020
Upgrades
JP Morgan upgraded the stock for Big Lots Inc (NYSE: BIG) from Underweight to Neutral. In the fourth quarter, Big Lots showed an EPS of $2.39, compared to...
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs
12:00pm, Thursday, 09'th Apr 2020
CRISPR is key to the cancer drugs that Tango Therapeutics is developing, but the startup isn’t out to edit disease-causing genes. Tango uses technology as
Evercore bearish on medical device makers in premarket analyst action
11:32am, Thursday, 09'th Apr 2020
Inspire Medical Systems (NYSE:INSP) initiated with Overweight rating and $74 (19% upside) price target at Piper Sandler.Prevail Therapeutics (NASDAQ:PRVL) initiated with Overweight rating and $20 (46%
Clovis Oncology (CLVS) Gains As Market Dips: What You Should Know
09:50pm, Friday, 03'rd Apr 2020
Clovis Oncology (CLVS) closed the most recent trading day at $6.10, moving +0.49% from the previous trading session.
Clovis Oncology (CLVS) Gains As Market Dips: What You Should Know
09:50pm, Friday, 03'rd Apr 2020
Clovis Oncology (CLVS) closed the most recent trading day at $6.10, moving +0.49% from the previous trading session.
Clovis Oncology (CLVS) Gains As Market Dips: What You Should Know
12:00am, Friday, 03'rd Apr 2020Clovis Oncology (NASDAQ:CLVS) Shares Down 2.6%
09:10am, Thursday, 02'nd Apr 2020
Clovis Oncology (NASDAQ:CLVS) fell 2.6% on Tuesday . The stock traded as low as $6.25 and last traded at $6.26, 220,041 shares traded hands during trading. A decline of 97% from the average session vo
